To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa2366
Peptide Name Sequence 3 from CN118725023A
Sequence GRLQSLQ
Sequence Length 7
Source Synthetic construct
Target Organism COVID-19
Patent Type Patent Application
Publication Date 2024-10-01
Patent No CN118725023A
Family Info CN 118725023 A
Patent Title Design of antiviral peptide and application of antiviral peptide in inhibition of activity of main protease of new coronavirus
Comment
Abstract The four antiviral peptides with the activity of inhibiting the main protease of the new coronavirus have the following amino acid sequences. Experiments prove that the S202301, the S202303, the S202305 and the S202307 have very good inhibitory activity on the main protease of the new coronavirus. The invention discloses amino acid sequences of four antiviral peptides and main protease inhibition activity. And S202301: IRLQAEAS202301: LMLQAEPS 202305: GRLQSLQS202307: VQRQAFN, and S202301: LMLQAEPS 202305: GRLQSLQS202307: GQRQAFN
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.